All the information you need about HOLDING BB BIO LAB to develop and secure your business in France

| Deposit | Confidentiality | closing date | document |
|---|---|---|---|
| 2022-06-22 | Public | 2021-07-31 | Complete |
| 2021-03-12 | Public | 2019-07-31 | Complete |
| 2021-02-24 | Public | 2020-07-31 | Complete |
| 2019-04-05 | Public | 2017-07-31 | Complete |
| 2018-11-02 | Public | 2018-07-31 | Complete |
| 2017-03-24 | Public | 2016-07-31 | Complete |
| Name | HOLDING BB BIO LAB |
| Siren | 538746496 |
| Closing | 2016-07-31 |
| Registry code | 3302 |
| Registration number | 4401 |
| Management number | 2011B04662 |
| Activity code | 6420Z |
| Closing date n-1 | 2015-07-31 |
| Duration Fiscal year | 12 |
| Duration Fiscal year n-1 | 12 |
| Filing date | 2017-03-24 |
| Modification | 00 Annual accounts entered without anomaly |
| Balance sheet type | C : Complete |
| Currency code | EUR |
| Confidentiality | Public |
| Address | 33440 AMBARES ET LAGRAVE |
| 1 - Assets (balance sheet) | Gross amount year N | Amortization year N | Net year N | Net year N-1 |
BB Receivables related to investments | 2 988 586.00 | 2 988 586.00 | 2 988 586.00 | |
BJ TOTAL (I) | 2 988 586.00 | 2 988 586.00 | 2 988 586.00 | |
BZ Other receivables | 235 983.00 | 235 983.00 | 235 983.00 | |
CF Cash and cash equivalents | 10 122.00 | 10 122.00 | 10 122.00 | |
CJ TOTAL (II) | 246 105.00 | 246 105.00 | 246 105.00 | |
CO Grand total (0 to V) | 3 234 690.00 | 3 234 690.00 | 3 234 690.00 | |
| 2 - Liabilities (balance sheet) | Amount year N | Amount year N-1 | ||
242 Other external expenses | 4 076.00 | 11 711.00 | 4 076.00 | |
264 Total operating expenses | 4 076.00 | 11 711.00 | 4 076.00 | |
270 Operating profit | -4 076.00 | -11 711.00 | -4 076.00 | |
280 Financial income | 265 583.00 | 208 800.00 | 265 583.00 | |
294 Financial expenses | 32 255.00 | 24 964.00 | 32 255.00 | |
300 Exceptional expenses | 2 701.00 | 250.00 | 2 701.00 | |
310 Profit or loss | 226 552.00 | 171 875.00 | 226 552.00 | |
DA Share or individual capital | 681 600.00 | 600 000.00 | 681 600.00 | |
DB Share, merger, contribution premiums, etc. | 384 127.00 | 237 859.00 | 384 127.00 | |
DD Legal reserve (1) | 60 000.00 | 40 000.00 | 60 000.00 | |
DG Other reserves | 309 933.00 | 158 058.00 | 309 933.00 | |
DI RESULTS FOR THE YEAR (Profit or Loss) | 226 552.00 | 171 875.00 | 226 552.00 | |
DK Regulated provisions | 2 951.00 | 250.00 | 2 951.00 | |
DL TOTAL (I) | 1 665 162.00 | 1 208 042.00 | 1 665 162.00 | |
DU Loans and Debts from Credit Institutions (3) | 1 566 947.00 | 1 450 584.00 | 1 566 947.00 | |
DV Miscellaneous Loans and Financial Debts (4) | 12 915.00 | |||
DX Trade payables and related accounts | 2 332.00 | 1 735.00 | 2 332.00 | |
EA Other liabilities | 250.00 | 1 500.00 | 250.00 | |
EC TOTAL (IV) | 1 569 529.00 | 1 466 734.00 | 1 569 529.00 | |
EE Grand total (I to V) | 3 234 690.00 | 2 674 775.00 | 3 234 690.00 | |
| 8 - Receivables and payables | Gross amount | Amount within 1 year | Amount 1 to 5 years | Amount more than 5 years |
8B Suppliers and Related Accounts | 2 332.00 | 2 332.00 | 2 332.00 | |
8K Other liabilities (including liabilities related to repo transactions) | 250.00 | 250.00 | 250.00 | |
VH Loans with a maturity of more than one year at origin | 1 566 947.00 | 208 241.00 | 869 578.00 | 1 566 947.00 |
VJ Loans taken out during the year | 285 000.00 | 285 000.00 | ||
VK Loans repaid during the year | 168 536.00 | 168 536.00 | ||
VT TOTAL – STATEMENT OF RECEIVABLES | 235 983.00 | 235 983.00 | 235 983.00 | |
VY TOTAL – STATEMENT OF LIABILITIES | 1 569 529.00 | 210 823.00 | 869 578.00 | 1 569 529.00 |
